Pharmaceuticals Startups Pharmaceutical Industry Drug Development Genetic Testing Pharmaceutical Companies Acquisitions Life Sciences Clinical Trials Gene Therapies
The FDA granted Fast Track status in February after strong midstage data highlighted its potential to address unmet needs in moderate-to-severe atopic dermatitis.